HAHN MATHEW A 4
4 · ACCELRYS, INC. · Filed Nov 19, 2012
Insider Transaction Report
Form 4
ACCELRYS, INC.ACCL
HAHN MATHEW A
VP, Research and Development
Transactions
- Sale
Common stock
2012-11-15$8.60/sh−10,000$86,036→ 0 total
Footnotes (1)
- [F1]Disposition of comon stock acquired through sale of Scitegic to Accelrys in 2004.